IMA
ImageneBioCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
IMA vs peer average
63/100
IMA vs. peer average (C vs. D)
Grade spread
A 1 · B 2 · C 1 · D 1 · F 6
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ACRV is the first available peer comparator.
Loose same-sector/same-size clinical biotech comp from the packet; useful mainly as a reminder that sub-$100M biotech valuations are dominated by financing and readout timing rather than fundamentals.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IMA
ImageneBio
ACRV
Acrivon Therapeutics
Grade
C
B
Momentum
58
88
Value
57
58
Sentiment
43
28
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs ACRV
IMA / ACRV
Grade Position
In line
IMA vs. peer average (C vs. D)
63/100
Momentum
58
ACRVValue
57
ACRVSentiment
43
IMARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IMA
ACRV is the first peer returned for this comparison set.